Jon Kessler Sells 1,332 Shares of Healthequity Inc (HQY) Stock

Healthequity Inc (NASDAQ:HQY) CEO Jon Kessler sold 1,332 shares of the business’s stock in a transaction that occurred on Wednesday, February 14th. The stock was sold at an average price of $55.00, for a total value of $73,260.00. Following the transaction, the chief executive officer now directly owns 446,332 shares in the company, valued at approximately $24,548,260. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Jon Kessler also recently made the following trade(s):

  • On Friday, February 16th, Jon Kessler sold 20,442 shares of Healthequity stock. The stock was sold at an average price of $55.02, for a total value of $1,124,718.84.
  • On Thursday, January 25th, Jon Kessler sold 40,000 shares of Healthequity stock. The stock was sold at an average price of $49.47, for a total value of $1,978,800.00.

Shares of Healthequity Inc (NASDAQ:HQY) opened at $54.86 on Friday. The stock has a market capitalization of $3,328.52, a P/E ratio of 74.14, a P/E/G ratio of 2.09 and a beta of 1.70. Healthequity Inc has a 12 month low of $37.62 and a 12 month high of $55.34.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. The business had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm’s revenue for the quarter was up 31.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 earnings per share. equities analysts expect that Healthequity Inc will post 0.73 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HQY. UBS Asset Management Americas Inc. lifted its stake in Healthequity by 24.3% during the second quarter. UBS Asset Management Americas Inc. now owns 28,342 shares of the company’s stock worth $1,412,000 after purchasing an additional 5,544 shares during the last quarter. California Public Employees Retirement System lifted its stake in Healthequity by 2.2% during the second quarter. California Public Employees Retirement System now owns 92,200 shares of the company’s stock worth $4,594,000 after purchasing an additional 2,000 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Healthequity by 25.3% during the second quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock worth $23,591,000 after purchasing an additional 95,514 shares during the last quarter. Shelton Capital Management bought a new stake in Healthequity during the second quarter worth $217,000. Finally, State Street Corp lifted its stake in Healthequity by 10.8% during the second quarter. State Street Corp now owns 1,172,117 shares of the company’s stock worth $58,411,000 after purchasing an additional 114,294 shares during the last quarter. Hedge funds and other institutional investors own 98.63% of the company’s stock.

HQY has been the topic of a number of recent analyst reports. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research report on Friday, December 22nd. Cantor Fitzgerald reissued a “buy” rating and set a $56.00 price target on shares of Healthequity in a research report on Tuesday, December 5th. Citigroup assumed coverage on Healthequity in a research report on Thursday, January 4th. They issued a “buy” rating on the stock. JPMorgan Chase & Co. decreased their target price on Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 24th. Finally, Zacks Investment Research downgraded Healthequity from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Healthequity currently has a consensus rating of “Buy” and an average target price of $56.67.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://weekherald.com/2018/02/18/jon-kessler-sells-1332-shares-of-healthequity-inc-hqy-stock.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply